Video: Solta Medical Introduces Advanced Thermage Body Tip 16.0 for Faster Body Shaping and Contouring Treatments
January 15 2009 - 9:00AM
PR Newswire (US)
Larger Tip Enables Physicians to Perform Thermage Body Area
Treatments Twice as Fast and Improves Patient Treatment Experience
HAYWARD, Calif., Jan. 15 /PRNewswire-FirstCall/ -- Solta Medical,
Inc. (NASDAQ:SLTM) today announced the launch of its new Body Tip
16.0 for the Thermage NXT system for faster, more comfortable body
shaping, contouring and cellulite treatments. With five times the
surface area coverage of traditional Thermage tips, Body Tip 16.0
cuts body shaping and contouring procedure time in half. In
addition, the introduction of an innovative energy delivery system,
Comfort Pulse Technology, to the Body Tip 16.0 helps improve
overall patient comfort. To view the Multimedia News Release, go
to: http://www.prnewswire.com/mnr/thermage/36633/ "The improved
patient comfort associated with the Thermage Body Tip 16.0 provides
a significant benefit to my patients, who get the same or better
tightening and contouring results with improved comfort," said
Robert Weiss, MD, of the Maryland Laser, Skin and Vein Institute.
"In addition, the shorter procedure time improves the experience
for my staff and the overall value for my practice." To increase
comfort for patients, the Body Tip 16.0 uses Comfort Pulse
Technology, a proprietary energy delivery system that gradually
reduces the amount of energy delivered in a succession of short,
rapid pulses during treatment. By tapering the amount of heat
applied in each pulse, patients enjoy more tolerable treatments,
while still maintaining the same body tightening and firming
results from Thermage treatments. "The Body Tip 16.0 offers new
levels of speed and comfort to my patients who are seeking the
benefits of Thermage body shaping treatments including advanced
skin tightening and firming," said Michael Kaminer, SkinCare
Physicians of Chestnut Hill, MA. "For the first time, I am now able
to complete body contouring procedures in under an hour with less
discomfort, yet still provide the same positive results that
patients expect from Thermage non-invasive aesthetics treatments."
Deep heating and cooling capabilities also ensure that physicians
can treat body shaping and cellulite patients with a single tip.
These product enhancements enable more treatments to be performed
in the same amount of time as well as the type of body areas that
can be treated with the Thermage NXT system. "Thermage is committed
to developing breakthrough products that increase physician and
patient satisfaction," said Stephen J. Fanning, Chairman of the
Board, President and CEO of Thermage. "The Body Tip 16.0 is another
example of how we continue to innovate to improve upon the value of
Thermage treatments for our physician customers, providing them
with tools to enhance their treatment offerings and also increase
the viability of their businesses." The Thermage Body Tip 16.0 is
now available worldwide. The tip recently received European CE Mark
approval and received clearance from the U.S. Food and Drug
Administration in January 2008. ABOUT SOLTA MEDICAL, INC. Solta
Medical develops innovative products that meet and exceed the needs
of the growing aesthetic market. We engineer safe, effective
solutions for patients and deliver compelling business
opportunities for physicians. To uphold that mission, we are
committed to superior innovation, research, development and
testing. Solta Medical is a collaboration of the industry's two
leading brands: Thermage, the pioneer in non-invasive skin
tightening and contouring, and Fraxel, the premier solution for
skin resurfacing. The Thermage and Fraxel systems, both delivering
non-invasive treatments with minimal recovery time, enable
physicians to offer more compelling solutions to the rapidly
growing anti-aging market. For more information about Solta
Medical, call 1-877-782-2286 or log on to http://www.solta.com/.
This press release may contain forward-looking statements within
the meaning of the U.S. Private Securities Litigation Reform Act of
1995. Forward-looking statements are based on management's current,
preliminary expectations and are subject to risks and
uncertainties, which may cause Thermage's actual results to differ
materially from the statements contained herein. Further
information on potential risk factors that could affect Thermage's
business are detailed in the Company's Form 10-Q for the period
ended September 30, 2007. Undue reliance should not be placed on
forward-looking statements, which speaks only as of the date they
are made. Thermage undertakes no obligation to update publicly any
forward-looking statements to reflect new information, events or
circumstances after the date they were made, or to reflect the
occurrence of unanticipated events. All our claims are based upon
our FDA clearance for the non-invasive treatment of wrinkles and
rhytids, including the upper and lower eyelids, and our FDA
clearance for the temporary improvement in the appearance of
cellulite. Side effects are generally mild and may include redness,
swelling, blisters, bumps and rare instances of surface
irregularities. Solta Medical, Thermage, and NXT, are trademarks of
Solta Medical, Inc.
http://www.prnewswire.com/mnr/thermage/36633DATASOURCE: Solta
Medical, Inc. CONTACT: Chris Lalli of Cohn & Wolfe,
+1-415-365-8540, Web Site: http://www.solta.com/
Copyright
Solta Medical, (MM) (NASDAQ:SLTM)
Historical Stock Chart
From Jun 2024 to Jul 2024
Solta Medical, (MM) (NASDAQ:SLTM)
Historical Stock Chart
From Jul 2023 to Jul 2024